Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Corticotherapy (Hydrocortisone Alone Versus Hydrocortisone Plus Fludrocortisone) Versus Corticotherapy Plus Intensive Insulin Therapy for Septic Shock

NCT00320099 is registered in ClinicalTrials.gov with University of Versailles as lead sponsor.

NCT NCT00320099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00320099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Corticotherapy (Hydrocortisone Alone Versus Hydrocortisone Plus Fludrocortisone) Versus Corticotherapy Plus Intensive Insulin Therapy for Septic Shock
Lead sponsor
University of Versailles
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
February 28, 2009
Enrollment
508 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock